Am J Med 119(4):354 e311359 Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, Bilker WB, Pettitt D (2003) Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics
Regular follow-up appointments with your healthcare provider will help track improvements and adjust the treatment plan if necessary
Future endeavors should concentrate on merging advancements in multi-omics technologies to monitor interindividual metabolic variabilities, emphasizing early diagnosis and personalized therapeutic strategies
The metabolism of PF is relatively rapid, with a short half-life, indicating that it may require multiple dosing to maintain therapeutic concentrations in the bloodstream
Epigenetic variation and human disease
[DOI] [PMC free article] [PubMed] [Google Scholar] 59.Doskoil L., Grasset L., Vlkov D., Peka M